Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Stieglbauer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of the Neurological Sciences|March 22, 2017
10-year-outcomes after rituximab for myasthenia gravis: Efficacy, safety, costs of inhospital care, and impact on childbearing potentialKarl Stieglbauer, Robert Pichler, Raffi Topakian
The Lancet. Neurology|August 21, 2007
Unexplained cerebral vasculitis and stroke: keep Lyme neuroborreliosis in mindRaffi Topakian, Karl Stieglbauer, Franz T Aichner
Muscle & Nerve|July 21, 2016
A Bodybuilder With Weak Hands and Feet: Corticosteroid-Responsive Pure Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following Anabolic Steroid UseRaffi Topakian, Karl Stieglbauer, Thomas Wolfsegger, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 24, 2008
Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledgeRaffi Topakian, Karl Stieglbauer, Karin Nussbaumer, et al.
AJNR. American Journal of Neuroradiology|September 12, 2002
MR changes after acute cyanide intoxicationJohanna Rachinger, Franz A Fellner, Karl Stieglbauer, et al.
Neuromuscular Disorders : NMD|May 27, 2009
Beneficial effect of rituximab monotherapy in multifocal motor neuropathyKarl Stieglbauer, Raffi Topakian, Georg Hinterberger, et al.
Parkinsonism & Related Disorders|March 1, 2005
Cyanide-induced akinetic rigid syndrome: clinical, MRI, FDG-PET, beta-CIT and HMPAO SPECT findingsJohn J Zaknun, Karl Stieglbauer, Johannes Trenkler, et al.
Journal of the Neurological Sciences|March 11, 2009
Rituximab for myasthenia gravis: three case reports and review of the literatureKarl Stieglbauer, Raffi Topakian, Viktoria Schäffer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2010
Segmental innervation in lumbosacral transitional vertebrae (LSTV): a comparative clinical and intraoperative EMG studyPhilipp Hinterdorfer, Babak Parsaei, Karl Stieglbauer, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 21, 2009
Reversibility of basilar artery stenosis following timely treatment of temporal arteritisRaffi Topakian, Karl Stieglbauer, Karin Nussbaumer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of the Neurological Sciences|March 22, 2017
10-year-outcomes after rituximab for myasthenia gravis: Efficacy, safety, costs of inhospital care, and impact on childbearing potentialKarl Stieglbauer, Robert Pichler, Raffi Topakian
The Lancet. Neurology|August 21, 2007
Unexplained cerebral vasculitis and stroke: keep Lyme neuroborreliosis in mindRaffi Topakian, Karl Stieglbauer, Franz T Aichner
Muscle & Nerve|July 21, 2016
A Bodybuilder With Weak Hands and Feet: Corticosteroid-Responsive Pure Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following Anabolic Steroid UseRaffi Topakian, Karl Stieglbauer, Thomas Wolfsegger, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 24, 2008
Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledgeRaffi Topakian, Karl Stieglbauer, Karin Nussbaumer, et al.
AJNR. American Journal of Neuroradiology|September 12, 2002
MR changes after acute cyanide intoxicationJohanna Rachinger, Franz A Fellner, Karl Stieglbauer, et al.
Neuromuscular Disorders : NMD|May 27, 2009
Beneficial effect of rituximab monotherapy in multifocal motor neuropathyKarl Stieglbauer, Raffi Topakian, Georg Hinterberger, et al.
Parkinsonism & Related Disorders|March 1, 2005
Cyanide-induced akinetic rigid syndrome: clinical, MRI, FDG-PET, beta-CIT and HMPAO SPECT findingsJohn J Zaknun, Karl Stieglbauer, Johannes Trenkler, et al.
Journal of the Neurological Sciences|March 11, 2009
Rituximab for myasthenia gravis: three case reports and review of the literatureKarl Stieglbauer, Raffi Topakian, Viktoria Schäffer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2010
Segmental innervation in lumbosacral transitional vertebrae (LSTV): a comparative clinical and intraoperative EMG studyPhilipp Hinterdorfer, Babak Parsaei, Karl Stieglbauer, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 21, 2009
Reversibility of basilar artery stenosis following timely treatment of temporal arteritisRaffi Topakian, Karl Stieglbauer, Karin Nussbaumer, et al.
Pageof 2